Quantity size:
0.1ml
Concentration:
1mg/ml 磷酸化赖氨酸缺陷型蛋白激酶1抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
WNK1 controls sodium and chloride ion transport by inhibiting the activity of WNK4, potentially by either phosphorylating the kinase or via an interaction between WNK4 and the autoinhibitory domain of WNK1. WNK4 regulates the activity of the thiazide sensitive Na/Cl cotransporter, SLC12A3, by phosphorylation. WNK1 may also play a role in actin cytoskeletal reorganization.磷酸化赖氨酸缺陷型蛋白激酶1抗体 WNK1 has 4 isoforms produced by alternative splicing. WNK1 is widely expressed, with highest levels observed in the testis, heart, kidney and skeletal muscle. Defects in WNK1 are a cause of pseudohypoaldosteronism type II (PHAII), an autosomal dominant disease characterized by severe hypertension, hyperkalemia, and sensitivity to thiazide diuretics which may result from a chloride shunt in the renal distal nephron.
磷酸化赖氨酸缺陷型蛋白激酶1抗体Also known as:
Erythrocyte 65 kDa protein; HSAN2; HSN2; hWNK1; KDP; KIAA0344; Kinase deficient protein; MGC163339; MGC163341; p65; PRKWNK1; Prostate derived sterile 20 like kinase; Protein kinase lysine deficient 1; Protein kinase lysine-deficient 1; Protein kinase with no lysine 1; PSK; Serine/threonine protein kinase WNK1; Serine/threonine-protein kinase WNK1; With no K;磷酸化赖氨酸缺陷型蛋白激酶1抗体 WNK lysine deficient protein kinase 1; WNK1; WNK1_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Rabbit, .
●
Immunogen: KLH conjugated Synthesised phosphopeptide derived from human WNK1 around the phosphorylation site of Thr60.
●
磷酸化赖氨酸缺陷型蛋白激酶1抗体Predicted Molecular Weight: 251kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user
kl545Po01免疫球蛋白E(IgE)多克隆抗体Polyclonal Antibody to Immunoglobulin E (IgE)
kl050Gu01胰岛素样生长因子1(IGF1)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor 1 (IGF1)
kl050Rb51胰岛素样生长因子1(IGF1)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor 1 (IGF1)
kl050Si01胰岛素样生长因子1(IGF1)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor 1 (IGF1)
kl050Ca01胰岛素样生长因子1(IGF1)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor 1 (IGF1)
kl050Po01胰岛素样生长因子1(IGF1)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor 1 (IGF1)
kl050Bo01胰岛素样生长因子1(IGF1)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor 1 (IGF1)
kl050Ga01胰岛素样生长因子1(IGF1)多克隆抗体Polyclonal Antibody to Insulin Like Growth Factor 1 (IGF1)
kl544Gu01免疫球蛋白G(IgG)多克隆抗体Polyclonal Antibody to Immunoglobulin G (IgG)
kl544Rb52免疫球蛋白G(IgG)多克隆抗体Polyclonal Antibody to Immunoglobulin G (IgG)
kl544Fe01免疫球蛋白G(IgG)多克隆抗体Polyclonal Antibody to Immunoglobulin G (IgG)
kl074Hu01免疫球蛋白G1(IgG1)多克隆抗体Polyclonal Antibody to Immunoglobulin G1 (IgG1)
kl074Mu01免疫球蛋白G1(IgG1)多克隆抗体Polyclonal Antibody to Immunoglobulin G1 (IgG1)
kl094Mu01免疫球蛋白G2α(IgG2α)多克隆抗体Polyclonal Antibody to Immunoglobulin G2a (IgG2a)
kl094Rb51免疫球蛋白G2α(IgG2α)多克隆抗体Polyclonal Antibody to Immunoglobulin G2a (IgG2a)
kl107Mu01免疫球蛋白G2β(IgG2β)多克隆抗体Polyclonal Antibody to Immunoglobulin G2b (IgG2b)
kl107Rb51免疫球蛋白G2β(IgG2β)多克隆抗体Polyclonal Antibody to Immunoglobulin G2b (IgG2b)
kl080Hu01白介素8(IL8)多克隆抗体Polyclonal Antibody to Interleukin 8 (IL8)
kl080Gu01白介素8(IL8)多克隆抗体Polyclonal Antibody to Interleukin 8 (IL8)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话